Health in Lower-middle income (World Bank) 156 indicators covering health for Lower-middle income (World Bank). IndicatorLatest Year10-yr change Rank ex - expectation of life at age x 67.22 2021 up 0.3% 9th ndx - number of people dying between ages x and x+n 3,448 2021 down 26.3% 4th Cases started on MDR-TB treatment 83,518 2024 up 91.2% 2nd Raised fasting blood glucose (>=7.0 mmol/L) 8.9 2014 up 15.6% 3rd Raised fasting blood glucose (>= 7.0 mmol/L) 7.7 2014 up 24.2% 8th Percentage of total deaths due to NCDs overall and percentage of 29.12 2019 down 31.9% 3rd Low birth weight prevalence 19.4% 2020 down 10.2% 2nd Inactivated first-dose polio vaccine (IPV1) immunization coverage 87.0% 2025 up 521.4% 7th Low birth weight number 12,421 2020 down 11.2% 4th Concentrations of fine particulate matter 41.47 2023 down 19.4% 2nd New or unknown treatment history cases: Pulmonary, bacteriologically 2.33 million 2023 up 73.4% 2nd Number of children aged 6-59 months with anaemia 151,831 2019 down 6.9% 2nd Prevalence of anaemia in children aged 6-59 months 50.0% 2019 down 10.1% 3rd Number of deaths attributed to non-communicable diseases, by type of 1.98 million 2019 up 32.5% 6th HIV-positive TB patients on ART (antiretroviral therapy) 95.0% 2024 up 20.3% 3rd Treatment success rate for patients treated for MDR-TB 76.0% 2022 up 46.2% 3rd Treatment success rate: HIV-positive TB cases 84 2023 up 31.2% 2nd Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 70.0% 2025 — 9th Number of prevalent tuberculosis cases 7.80 million 2014 down 22.0% 2nd Japanese encephalitis - number of reported cases 1,666 2025 down 40.8% 2nd Neonates protected at birth against neonatal tetanus (PAB) 87.0% 2022 up 6.1% 7th HPV immunization coverage estimates among primary target cohort (9-14) 27.0% 2025 — 8th Tuberculosis - new and relapse cases 2.64 million 2011 up 49.2% 2nd Total number of notified TB cases 3.59 million 2014 up 42.7% 2nd Underweight numbers among children under 5 years of age (millions) 54,484 2024 down 24.5% 4th Underweight prevalence among children under 5 years of age (%) 17.7% 2024 down 23.4% 3rd Smear-positive tuberculosis treatment-success rate 88.0% 2011 up 33.3% 3rd Insufficiently active 79.26 2016 down 1.3% 10th Yellow fever vaccine (YFV) immunization coverage among 1-year olds 55.0% 2025 up 14.6% 4th Preterm birth rate 10.95 2020 down 1.4% 2nd Preterm birth 7.63 million 2020 down 3.6% 2nd Treatment success rate: XDR-TB cases 73 2022 up 151.7% 2nd Confirmed cases of MDR-TB 31,469 2012 up 1,820.0% 4th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 86.0% 2014 up 59.3% 4th Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) 36.0% 2025 up 3,500.0% 2nd Confirmed cases of MDR-TB started treatment for MDR-TB 85.0% 2012 — 3rd ← Previous Page 3 of 3